PMA

P180001: Zenith Dissection Endovascular System

FDA PMA · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT · William Cook Europe Aps

Key facts

PMA number P180001
Trade name Zenith Dissection Endovascular System
Generic name SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Applicant William Cook Europe Aps
Owner/operator WILLIAM COOK EUROPE APS
Product code MIH
Approval date Dec 31, 2018
Docket number 19M-0028
Notice date Jan 25, 2019
Establishment registration 3002808486
FEI number 3002808486

At a glance

  • 10–99 Supplements
  • Aug 4, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 10–99 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals